In Vitro Fertilization /IVF Market Size, Share & Analysis Report, 2022-2030
The global In Vitro Fertilization /IVF market size was estimated at USD 638 million in 2021 and is expected to surpass around USD 2.4 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 14.9% during the forecast period 2022 to 2030. The key factors propelling the growth of this market include greater public awareness about infertility and the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain extent.
COVID-19 Impact on the global in vitro fertilization market
COVID-19 pandemic triggered the worldwide suspension of in vitro fertilization treatment; this had a profound impact on women undergoing IVF procedures. In India, 30 lakh people seek IVF every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles worldwide. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who had opted for IVF treatment before the pandemic.
Report Scope of the In Vitro Fertilization /IVF Market
|
Report Coverage |
Details |
|
Market Size |
US$ 2.4 Billion by 2030 |
|
Growth Rate |
CAGR of 14.9% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Product, cycle, Type, End user and Region, |
|
Companies Mentioned |
The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Gynotec B.V. (Netherlands |
In vitro fertilization Market Dynamics
Driver: Growth in median age of first-time mothers
Over the years, the median age of first-time mothers has increased significantly across the globe. This trend can largely be attributed to improved contraceptive techniques, late marriages, and the growing number of women prioritizing their careers over starting a family. According to the data published by Australian Institute of Health and Welfare 2021, in Australia the average age of first-time mothers increased from 27.9 years in 2009 to 31.9 years in 2019. With the median age for first-time mothers increasing, a growing number of women are expected to face difficulties in conceiving naturally. In this scenario, an increasing number of women are forced to opt for IVF treatments; this is expected to drive the growth of the IVF market in the coming years.
Restraint: High costs associated with IVF procedures
More than 2.5 million vitro fertilization (IVF) cycles are performed every year worldwide. The cost of IVF treatment varies from country to country due to the lack of reimbursement policies. A lack of insurance coverage and the poor reimbursement scenario in some parts of the world are limiting the growth of this market.
Opportunity: Increasing Medical Tourism in Emerging Nations
The medical tourism industry in emerging countries is thriving owing to a number of factors. Brazil has ~150 centers offering infertility treatments and over 20 medical centers [Source: Fertility Treatment Abroad]. A typical IVF cycle in the US costs around USD 12,000, whereas in Brazil, the same can be completed in USD 4,000. With more than 500 individual IVF centers, India is one of the most affordable destinations for in vitro fertilization (IVF) and other infertility treatments worldwide. Healthcare treatments cost up to 90% less in India as compared to the USA typical IVF cycle in the US costs around USD 12,000, while in India, the same can be completed in USD 2,000–USD 3,000.
Challenge: Reducing efficacy of infertility treatment among patients with advancing age
The changing social scenario has resulted in an increasing number of older women seeking help from infertility clinics. The risk of complications in pregnancy and childbirth also increases with age. A woman aged 35 or above is 2.5 times more prone to have a miscarriage or stillbirth than a woman aged less than 35, whereas a woman aged above 40 is more than five times prone to have a miscarriage or stillbirth than a woman under 35 years of age. The declining success rates of IVF treatment procedures in patients with advancing age has become one of the major challenge for IVF market.
The equipment to capture the largest share in in vitro fertilization market, by products during the forecast period.
The equipment segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the increasing number of IVF procedures and introduction of highly advanced IVF equipment by well-established manufacturers in the market.
The fresh non-donor segment to capture the largest market share of in vitro fertilization market, by the type of cycle in 2021.
The fresh non-donor segment captured the largest share of the market cycles during the forecast period. High success rates, ease in the implantation process, and enhanced embryo production are responsible for the large share of this segment.
The IVF with ICSI segment registered the highest growth rate of the in vitro fertilization market, by type, in 2021.
The IVF with ICSI segment registered the highest growth rate of the market. The success rate of fertilization with ICSI procedure, and the growing utilization of the ICSI during IVF procedure are anticipated to boost the adoption of IVF with ICSI procedures, accelerating the growth of the segment during the forecast period.
The fertility clinics segment accounted for the largest share of the in vitro fertilization market, by end user, in 2021.
The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, growing popularity of IVF & ICSI treatment globally are some of the factors likely to contribute towards the rapid growth of the segment.
Asia Pacific is the largest regional market for in vitro fertilization market
Asia Pacific dominates the market. Significant rise in the medical tourism, Increase in the awareness of availability of in vitro fertilization procedures, reduced IVF treatment procedures, growing fertility clinics in the region, rising healthcare expenditures, and growing adoption of assisted reproductive technology in the emerging nations.
Some of the prominent players in the In Vitro Fertilization /IVF Market include: The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Corning Corporation (US), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Eppendorf (Germany).
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global In Vitro Fertilization /IVF market
By Product
By Cycle
By Type
By End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in In Vitro Fertilization /IVF Market Study:
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers